Search alternatives:
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
therapeutic response » therapeutic research (Expand Search), therapeutic options (Expand Search)
shear resistance » wear resistance (Expand Search), stress resistance (Expand Search), tumor resistance (Expand Search)
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
therapeutic response » therapeutic research (Expand Search), therapeutic options (Expand Search)
shear resistance » wear resistance (Expand Search), stress resistance (Expand Search), tumor resistance (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Table 1_Navarixin alleviates cardiac remodeling after myocardial infarction by decreasing neutrophil infiltration and the inflammatory response.xlsx
Published 2025“…Through transcriptomic analysis, we found that Nav affects signaling pathways such as the innate immune response and the chemokine signaling pathway, thereby decreasing the inflammatory response by reducing neutrophil chemotaxis. …”
-
14
Table 3_Navarixin alleviates cardiac remodeling after myocardial infarction by decreasing neutrophil infiltration and the inflammatory response.xlsx
Published 2025“…Through transcriptomic analysis, we found that Nav affects signaling pathways such as the innate immune response and the chemokine signaling pathway, thereby decreasing the inflammatory response by reducing neutrophil chemotaxis. …”
-
15
Table 2_Navarixin alleviates cardiac remodeling after myocardial infarction by decreasing neutrophil infiltration and the inflammatory response.xlsx
Published 2025“…Through transcriptomic analysis, we found that Nav affects signaling pathways such as the innate immune response and the chemokine signaling pathway, thereby decreasing the inflammatory response by reducing neutrophil chemotaxis. …”
-
16
Supplementary Material for: Histological Predictors for Therapeutic Response to Integrin Inhibitors in Patients with Ulcerative Colitis
Published 2025“…Primary response (PR) was defined as a ≥3-point decrease in the partial Mayo score at 14 weeks. …”
-
17
-
18
-
19
-
20